Recall of Hospira Plum 360 Infusion pump

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Hospira Inc.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Recalling Organisation: Hospira NZ Ltd, 58 Richard Pearse Drive, Airport Oaks, Mangere, Auckland 2022
  • Reason
    Hospira has determined if "yes" is selected at the "new patient" screen, and the program was not cleared prior to powering off the infuser, the distal occlusion pressure setting is assigned a value of 15 psi (775 mmhg) instead of the default value. in addition, the user interface will incorrectly display the default distal occlusion pressure value, which is set at 6 psi (310 mmhg) from the manufacturer.
  • Action
    Software to be upgraded


  • Model / Serial
    Model: 30010-27, Affected: , Software version: 15.01.XX.009
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Source